Author’s note: Recently, a massive dose of ascorbic acid (Vitamin C) ended my 18-month post-mRNA illness, and I recalled a story Linus Pauling told me which, in light of recent Pharma scandals, deserves to see the light of day.
First Nobel
Pauling won his laurel two years later, for revolutionizing the study of chemistry and founding the field of molecular biology. In 1962, the Peace prize made him the the only person to win two unshared Nobels and, in 1980, he told me how he had missed a third.
As I remember it forty years later, this is what happened.
Chasing number three
Pauling published Campbell’s results and several well-received papers on the biochemical and physiological pathways of ascorbic acid. After Scientific American picked up the story, Vitamin C vanished from the shelves of every drugstore on earth. Today, it’s a $12 billion industry.1
Pauling also forwarded the trial results to the National Institutes of Health2 , asking them to perform a more rigorous, double-blind trial. The NIH’s form letter (‘mimeographed,’ he said) claimed that they were too busy, to which he tartly replied that he would personally investigate the work of any Medicine Nobelist they rejected.
Pauling next turned to Senator Ted Kennedy, then chair of the Senate Committee on Health, for help. A year later, reluctantly, the NIH announced a grant to the Mayo Clinic for a double-blind, randomized trial of Vitamin C. Pauling wrote the Mayo investigators, warning that patients whose immune systems had been destroyed by irradiation or chemicals should be excluded from the trial as the Scottish studies determined that ascorbic acid could not help them.
Five years later
Weeks later, Kennedy sent him documents showing that Mayo’s entire trial cohort consisted of twelve convicted criminals with compromised immune systems.
Whatever he may have felt at the time, Pauling’s only comment to me was that Big Science was one of the most politicized fields on earth. By then, he was busy with Kaiser Permanente Hospitals, working on predictive medicine.
He had developed advanced gas chromatographs that could break down newborns’ urine samples into thousands of chemical indicators and showed me how each chart’s peaks and valleys corresponded to (mostly mild) metabolic imbalances. New mothers, he said, would receive comprehensive information about their child’s likely potential deficits and allergies, along with suggestions how they might be rebalanced nutritionally. The investigation was abandoned immediately upon his death.
The moral of the story?
Let that sink in.
